These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6431618)

  • 1. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
    Thornhill DP
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of standard and slow-release oral lithium carbonate products.
    Wallis J; Miller R; McFadyen ML; Carlile JB
    S Afr Med J; 1989 Dec; 76(11):618-20. PubMed ID: 2512655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of lithium preparations in patients.
    Johnson GF; Hunt GE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
    Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
    J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of lithium after three proprietary preparations of lithium carbonate (Priadel, Phasal and Camcolit).
    Bennie EH; Manzoor AK; Scott AM; Fell GS
    Br J Clin Pharmacol; 1977 Aug; 4(4):479-83. PubMed ID: 901741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of dosage schedules for delayed-action lithium carbonate].
    Balon R; Kabesh Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):264-6. PubMed ID: 6803477
    [No Abstract]   [Full Text] [Related]  

  • 10. Absorption of lithium following administration of slow-release and conventional preparations.
    Tyrer S; Hullin RP; Birch NJ; Goodwin JC
    Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum lithium levels after slow-release and regular tablets of lithium carbonate].
    Kauko K; Viukari M
    Duodecim; 1973; 89(19):1324-8. PubMed ID: 4757404
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method.
    Marr MA; Djuric PE; Ritschel WA; Garver DL
    Clin Pharm; 1983; 2(3):243-8. PubMed ID: 6411413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Voluntary lithium salt poisoning; risks of slow release forms].
    Branger B; Peyrière H; Zabadani B; Vécina F; Abbar M
    Nephrologie; 2000; 21(6):291-3. PubMed ID: 11117108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects.
    Shelley RK; Silverstone T
    Int Clin Psychopharmacol; 1986 Oct; 1(4):324-31. PubMed ID: 3104448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The single-dose bioavailability of different lithium carbonate products.
    Tsang HY; Chen CC; Wen JK
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):543-8. PubMed ID: 3114414
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients.
    Johnson GF; Hunt GE; Lewis J; St George B
    Aust N Z J Psychiatry; 1982 Mar; 16(1):64-8. PubMed ID: 6810866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy and safety of a priori lithium loading.
    Kook KA; Stimmel GL; Wilkins JN; Spangher GG
    J Clin Psychiatry; 1985 Feb; 46(2):49-51. PubMed ID: 3918024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the dosage schedules during the administration of retarded lithium carbonate.
    Balon R; Kabes J
    Act Nerv Super (Praha); 1981 Dec; 23(4):278-80. PubMed ID: 6801905
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a slow-release lithium carbonate formulation.
    Cooper TB; Simpson GM; Lee JH; Bergner PE
    Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative characteristics of the preventive properties of short-acting and delayed-action lithium carbonate in endogenous affective psychoses].
    Panteleeva GP; Mikhaĭlova NM; Beliaev BS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):406-12. PubMed ID: 6789585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.